RPHM
Reneo Pharmaceuticals Inc
Price:  
1.82 
USD
Volume:  
437,523.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RPHM WACC - Weighted Average Cost of Capital

The WACC of Reneo Pharmaceuticals Inc (RPHM) is 6.6%.

The Cost of Equity of Reneo Pharmaceuticals Inc (RPHM) is 9.60%.
The Cost of Debt of Reneo Pharmaceuticals Inc (RPHM) is 5.00%.

Range Selected
Cost of equity 8.10% - 11.10% 9.60%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.9% - 7.4% 6.6%
WACC

RPHM WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.92 1.12
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.10% 11.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.9% 7.4%
Selected WACC 6.6%